HCM · NASDAQ
HUTCHMED (China) (HCM) Stock Price & Fundamentals
HUTCHMED (China) (HCM) closed at $496.08 on Oct 9, 2026, up 0.50% from the previous close of $493.60.
Share price, past year
1Y +26.53%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $496.08 |
| Sep 30, 2026 | $482.32 |
| Aug 31, 2026 | $494.39 |
| Jul 31, 2026 | $476.81 |
| Jun 30, 2026 | $470.62 |
| May 29, 2026 | $451.49 |
| Apr 30, 2026 | $475.12 |
| Mar 31, 2026 | $473.74 |
| Feb 27, 2026 | $448.39 |
| Jan 30, 2026 | $438.68 |
| Dec 31, 2025 | $447.10 |
| Nov 28, 2025 | $401.92 |
| Oct 31, 2025 | $405.64 |
Key statistics
- Market cap
- $432.74B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- —
- Shares outstanding
- 872.3M
- Dividend yield
- —
- 52-week range
- $388.13 – $496.08
HUTCHMED (China)'s market cap is $432.74B, based on a share price of $496.08 and 872.3M shares outstanding as of Dec 31, 2025.
Financials
HUTCHMED (China) reported revenue of $548.51M for fiscal 2025, down 12.96% from fiscal 2024.
HUTCHMED (China) earned net income of $456.91M in fiscal 2025, a net margin of 83.3%.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $548.51M | −13.0% | $456.91M | 83.3% | $0.52 | −$78.81M |
| FY2024ended Dec 31, 2024 | $630.20M | −24.8% | $37.73M | 6.0% | $0.04 | −$17.44M |
| FY2023ended Dec 31, 2023 | $838.00M | +96.5% | $100.78M | 12.0% | $0.12 | $186.65M |
| FY2022ended Dec 31, 2022 | $426.41M | +19.7% | −$360.84M | −84.6% | −$0.43 | −$305.26M |
| FY2021ended Dec 31, 2021 | $356.13M | +56.2% | −$194.65M | −54.7% | −$0.25 | −$220.62M |
| FY2020ended Dec 31, 2020 | $227.98M | +11.3% | −$125.73M | −55.2% | −$0.18 | −$70.02M |
| FY2019ended Dec 31, 2019 | $204.89M | −4.3% | −$106.02M | −51.8% | −$0.16 | −$89.48M |
| FY2018ended Dec 31, 2018 | $214.11M | −11.2% | −$74.81M | −34.9% | −$0.113 | −$39.21M |
| FY2017ended Dec 31, 2017 | $241.20M | +11.6% | −$26.74M | −11.1% | −$0.043 | −$13.96M |
| FY2016ended Dec 31, 2016 | $216.08M | — | $11.70M | 5.4% | $0.02 | −$13.90M |
Company profile
- Name
- HUTCHMED (China) Ltd
- Ticker
- HCM
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 48th Floor, Cheung Kong Center, 2 Queen'S Road Central, Hong Kong
- Incorporated in
- E9
- SEC CIK
- 0001648257
Frequently asked questions
What is HUTCHMED (China)'s stock price?
HUTCHMED (China) (HCM) closed at $496.08 on Oct 9, 2026, up 0.50% from the previous close of $493.60.
What is HUTCHMED (China)'s market cap?
HUTCHMED (China)'s market cap is $432.74B, based on a share price of $496.08 and 872.3M shares outstanding as of Dec 31, 2025.
How much revenue does HUTCHMED (China) make?
HUTCHMED (China) reported revenue of $548.51M for fiscal 2025, down 12.96% from fiscal 2024.
Sources and methodology
Fundamentals come from HUTCHMED (China) Ltd's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures